Received Mar 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMVB0799A | — |
received the liquid and not the powder; received the liquid and not the powder; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVB0799A, expiry date 31-MAY-2026) for prophylaxis. On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: received the liquid and not the powder) and inappropriate dose of vaccine administered (Verbatim: received the liquid and not the powder). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable.